Catecholaminergic Polymorphic Ventricular Tachycardia
Open Access
- 21 October 2022
- journal article
- review article
- Published by Radcliffe Medical Media Ltd in Arrhythmia and Electrophysiology Review
- Vol. 11, e20
Abstract
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia syndrome characterised by adenergically mediated bidirectional and/or polymorphic ventricular tachycardia. CPVT is a significant cause of autopsy-negative sudden death in children and adolescents, although it can also affect adults. It is often caused by pathogenic variants in the cardiac ryanodine receptor gene as well as other rarer genes. Early identification and risk stratification is of major importance. β-blockers are the cornerstone of therapy. Sodium channel blockers, specifically flecainide, have an additive role. Left cardiac sympathetic denervation is playing an increasing role in suppression of arrhythmia and symptoms. Concerns have been raised, however, about the efficacy of implantable cardioverter defibrillator therapy and the risk of catecholamine driven proarrhythmic storms. In this review, we summarise the clinical characteristics, genetics, and diagnostic and therapeutic strategies for CPVT and describe recent advances and challenges.Keywords
This publication has 72 references indexed in Scilit:
- Familial Evaluation in Catecholaminergic Polymorphic Ventricular TachycardiaCirculation: Arrhythmia and Electrophysiology, 2012
- Cardiac Channel Molecular Autopsy: Insights From 173 Consecutive Cases of Autopsy-Negative Sudden Unexplained Death Referred for Postmortem Genetic TestingMayo Clinic Proceedings, 2012
- Sudden Cardiac Death and Genetic Ion ChannelopathiesCirculation, 2012
- Follow-Up with Exercise Test of Effort-Induced Ventricular Arrhythmias Linked to Ryanodine Receptor Type 2 Gene MutationsThe American Journal of Cardiology, 2012
- Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literatureEP Europace, 2011
- Prevention of Ventricular Arrhythmia and Calcium Dysregulation in a Catecholaminergic Polymorphic Ventricular Tachycardia Mouse Model Carrying Calsequestrin-2 MutationJournal of Cardiovascular Electrophysiology, 2010
- Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular TachycardiaCirculation, 2009
- Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patientsJournal of Medical Genetics, 2005
- Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testingHeart Rhythm, 2005
- Spectrum and Frequency of Cardiac Channel Defects in Swimming-Triggered Arrhythmia SyndromesCirculation, 2004